Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Jan;84(1):259–264.

Cyclic nucleotides and contractility of isolated soleus muscle.

W C Bowman, F Y Lam, I W Rodger, M Shahid
PMCID: PMC1987223  PMID: 2983803

Abstract

The effects of isoprenaline, terbutaline and forskolin were examined on cyclic nucleotide concentrations and contractile responses in guinea-pig isolated soleus muscles. Isoprenaline and terbutaline induced rapid, concentration-related reductions in the tension and degree of fusion of subtetanic contractions of the soleus muscle. These changes were associated with increases (about 2 fold) in the levels of adenosine 3':5'-cyclic monophosphate (cyclic AMP) in the muscle cells. Propranolol competitively inhibited these responses. Forskolin failed to elicit a sympathomimetic response in the soleus muscles despite increasing (by about 20 fold) the intracellular concentration of cyclic AMP. Forskolin also failed to potentiate the effects induced by isoprenaline. The levels of cyclic GMP in the soleus were increased by isoprenaline (about 1.5 fold) and forskolin (about 2.5 fold). Terbutaline was without effect on cyclic GMP levels. These data suggest either that cyclic AMP is not involved as the mediator underlying beta-adrenoceptor-induced changes in contractility of slow contracting skeletal muscles or that forskolin does not stimulate the particular adenylate cyclase that leads to appropriate increases in cyclic AMP in those functional compartments associated with modulation of intracellular Ca2+ movements. Cyclic GMP is not involved in modifying changes in contractility of the soleus muscle.

Full text

PDF
259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Jeboory A. A., Marshall R. J. Correlation between the effects of salbutamol on contractions and cyclic AMP content of isolated fast-and slow-contracting muscles of the guinea pig. Naunyn Schmiedebergs Arch Pharmacol. 1978 Dec;305(3):201–206. doi: 10.1007/BF00498811. [DOI] [PubMed] [Google Scholar]
  2. Apperley G. H., Daly M. J. Simultaneous measurement of skeletal muscle, pulmonary mechanical and vascular responses to bronchodilators in the cat. J Pharm Pharmacol. 1972 Feb;24(2):152–153. doi: 10.1111/j.2042-7158.1972.tb08950.x. [DOI] [PubMed] [Google Scholar]
  3. BOWMAN W. C., RAPER C. THE EFFECTS OF SYMPATHOMIMETIC AMINES ON CHRONICALLY DENERVATED SKELETAL MUSCLES. Br J Pharmacol Chemother. 1965 Feb;24:98–109. doi: 10.1111/j.1476-5381.1965.tb02083.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BOWMAN W. C., ZAIMIS E. The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat. J Physiol. 1958 Nov 10;144(1):92–107. doi: 10.1113/jphysiol.1958.sp006088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bowman W. C., Nott M. W. Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle. Br J Pharmacol. 1970 Jan;38(1):37–49. doi: 10.1111/j.1476-5381.1970.tb10334.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bowman W. C., Nott M. W. Actions of sympathomimetic amines and their antagonists on skeletal muscle. Pharmacol Rev. 1969 Mar;21(1):27–72. [PubMed] [Google Scholar]
  7. Bowman W. C., Nott M. W. Effects of catecholamines, cyclic nucleotides and phosphodiesterase inhibitors on contractions of skeletal muscles in anaesthetized cats. Clin Exp Pharmacol Physiol. 1974 Jul-Aug;1(4):309–323. doi: 10.1111/j.1440-1681.1974.tb00553.x. [DOI] [PubMed] [Google Scholar]
  8. Brunton L. L., Hayes J. S., Mayer S. E. Functional compartmentation of cyclic AMP and protein kinase in heart. Adv Cyclic Nucleotide Res. 1981;14:391–397. [PubMed] [Google Scholar]
  9. Ebashi S. Excitation-contraction coupling. Annu Rev Physiol. 1976;38:293–313. doi: 10.1146/annurev.ph.38.030176.001453. [DOI] [PubMed] [Google Scholar]
  10. Fellenius E., Hedberg R., Holmberg E., Waldeck B. Functional and metabolic effects of terbutaline and propranolol in fast- and slow-contracting skeletal muscle in vitro. Acta Physiol Scand. 1980 May;109(1):89–95. doi: 10.1111/j.1748-1716.1980.tb06569.x. [DOI] [PubMed] [Google Scholar]
  11. Festoff B. W., Oliver K. L., Reddy N. B. In vitro studies of skeletal muscle membranes. Adenylate cyclase of fast and slow twitch muscle and the effects of denervation. J Membr Biol. 1977 Apr 22;32(3-4):331–343. doi: 10.1007/BF01905226. [DOI] [PubMed] [Google Scholar]
  12. Forte L. R., Bylund D. B., Zahler W. L. Forskolin does not activate sperm adenylate cyclase. Mol Pharmacol. 1983 Jul;24(1):42–47. [PubMed] [Google Scholar]
  13. Hayes J. S., Brunton L. L. Functional compartments in cyclic nucleotide action. J Cyclic Nucleotide Res. 1982;8(1):1–16. [PubMed] [Google Scholar]
  14. Holmberg E., Waldeck B. On the possible role of potassium ions in the action of terbutaline on skeletal muscle contractions. Acta Pharmacol Toxicol (Copenh) 1980 Feb;46(2):141–149. doi: 10.1111/j.1600-0773.1980.tb02434.x. [DOI] [PubMed] [Google Scholar]
  15. Holmberg E., Waldeck B. The effect of insulin on skeletal muscle contractions and its relation to the effect produced by BETA-adrenoceptor stimulation. Acta Physiol Scand. 1980 Jun;109(2):225–229. doi: 10.1111/j.1748-1716.1980.tb06590.x. [DOI] [PubMed] [Google Scholar]
  16. Merican Z., Nott M. W. Effects of isoprenaline, levodopa and a phosphodiesterase inhibitor (ICI 63,197) on cyclic AMP levels and contractions of soleus muscles in anesthetized cats. Clin Exp Pharmacol Physiol. 1981 Jan;8(1):57–66. doi: 10.1111/j.1440-1681.1981.tb00134.x. [DOI] [PubMed] [Google Scholar]
  17. Merican Z., Nott M. W., Sunbhanich M. Effects of increasing the frequency of twitches and of isoprenaline on maximal twitches and cyclic AMP levels in slow- and fast-contracting cat skeletal muscles. Br J Pharmacol. 1983 Oct;80(2):303–308. doi: 10.1111/j.1476-5381.1983.tb10034.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. POSNER J. B., STERN R., KREBS E. G. EFFECTS OF ELECTRICAL STIMULATION AND EPINEPHRINE ON MUSCLE PHOSPHORYLASE, PHOSPHORYLASE B KINASE, AND ADENOSINE 3',5'-PHOSPHATE. J Biol Chem. 1965 Mar;240:982–985. [PubMed] [Google Scholar]
  19. Rodger I. W., Shahid M. Forskolin, cyclic nucleotides and positive inotropism in isolated papillary muscles of the rabbit. Br J Pharmacol. 1984 Jan;81(1):151–159. doi: 10.1111/j.1476-5381.1984.tb10755.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Seamon K. B., Daly J. W. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res. 1981;7(4):201–224. [PubMed] [Google Scholar]
  21. Seamon K. B., Padgett W., Daly J. W. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3363–3367. doi: 10.1073/pnas.78.6.3363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sullivan A., Zaimis E. The effect of isoprenaline on cyclic AMP concentrations in skeletal muscle. J Physiol. 1973 Jun;231(2):102P–103P. [PubMed] [Google Scholar]
  23. Tashiro N. Effects of isoprenaline on contractions of directly stimulated fast and slow skeletal muscles of the guinea-pig. Br J Pharmacol. 1973 May;48(1):121–131. doi: 10.1111/j.1476-5381.1973.tb08229.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Vegesna R. V., Diamond J. Comparison of the effects of forskolin and isoproterenol on cyclic AMP levels and tension in bovine coronary artery. Can J Physiol Pharmacol. 1983 Oct;61(10):1202–1205. doi: 10.1139/y83-179. [DOI] [PubMed] [Google Scholar]
  25. Waldeck B. An in vitro method for the study of beta-receptor mediated effects on slow contracting skeletal muscle. J Pharm Pharmacol. 1976 May;28(5):434–436. doi: 10.1111/j.2042-7158.1976.tb04649.x. [DOI] [PubMed] [Google Scholar]
  26. Zahler W. L. Evidence for multiple interconvertible forms of adenylate cyclase detected by forskolin activation. J Cyclic Nucleotide Protein Phosphor Res. 1983;9(3):221–230. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES